was measured by the BCG (Bromo Cresol Green) method (Shino-Test Corporation, Tokyo, Japan). WBC was automatically counted using a cell counter (Sysmex NE8000).
Enzymatic methods were used to measure serum total cholesterol and low density lipoprotein (LDL) cholesterol (Daiichi Pure Chemicals, Tokyo, Japan), and uric acid and serum creatinine. High density lipoprotein (HDL) cholesterol was measured by a direct method (Wako Pure Chemical Industries, Osaka, Japan). We measured aspartate aminotransferase (AST), alanine aminotransferase (ALT), -glutamyl transpeptidase ( -GTP) as hepatic functions using an optimized method based on the recommendations of the Japan Society of Clinical Chemistry.
Intra-assay coefficients of variation for all blood measurements were reported to be less than 2% in this laboratory during the study period. Lipids measurements were standardized according to a protocol provided by the Centers for Disease Control and Prevention. 14 Trained persons measured blood pressure using a mercury sphygmomanometer on the right arm after at least a 5-min rest. Hypertension was defined as systolic blood pressure of 140 mmHg or more, diastolic blood pressure 90 mmHg or more, or current use of antihypertensive medication. Diabetes was defined as a fasting glucose concentration of 126 mg/dl or more, non-fasting glucose concentration of 200 mg/dl or more, or current diabetes therapy. Body mass index (kg/m 2 ) was computed from each participant's weight and height. Total body fat was calculated with a body fat calculator (TBF-310, Tanita, Tokyo, Japan) based on the leg-to-leg bioelectrical impedance analysis (BIA) method. We used the body fat data from individuals aged 40-69 because the BIA method is less reliable in the elderly (≥70 years).
Participants were asked if they had gained or lost weight and by how much since the age of 20. The weight change was then classified into one of 5 categories: 15 loss ≥10 kg, loss 4-9 kg, stable (change, <4 kg), gain 4-9 kg, and gain ≥10 kg. Additionally, participants were interviewed about weight changes in the past 6 months (gain ≥2 kg, loss ≥2 kg, and stable). The kappa for within-person agreement (n=884) on weight change from recall was 0.95 when assessed on occasions 1 year apart. The interviewers also assessed smoking status (current or non-smoker), alcohol consumption (current or non-drinker), and exercise habits (regularly exercise once a week or not).
We explained the purpose of the study to the subjects and indicated that the measurements of CRP, fibrinogen, and serum albumin were optional. The subjects gave informed consent and to protect their privacy, identifying information was deleted from the data set.
Data Analysis
Sex-and age-adjusted means by quartiles of CRP, fibrinogen, serum albumin, and WBC were calculated by analysis of covariance. Because of skewed distributions, CRP, AST, ALT, and -GTP values were translated into logarithms for calculation of means. To test the strength of associations, we calculated the partial correlation coefficients between log CRP, fibrinogen, serum albumin, and WBC and other variables investigated, adjusted for sex and age. Undetectable CRP values (<0.01 mg/dl) were recorded as 0.005 mg/dl when calculated. Logistic models were used to calculate multivariate-adjusted odds ratios of normal (BMI 18.5-24.9 kg/m 2 ), obese (BMI ≥25 kg/m 2 ), and high body fat (body fat ≥30% for men and ≥35% for women) for the highest quartile of CRP, fibrinogen, and WBC and the lowest quartile of serum albumin. The multivariate models were adjusted for hypertension, LDL cholesterol, HDL cholesterol, serum creatinine, log ALT, diabetes mellitus, smoking, alcohol consumption, and exercise. We used SAS software, version 8.0 (SAS Institute, Inc, Cary, North Carolina) for all analyses.
Results
The population characteristics are described in Table 1 . CRP, fibrinogen, serum albumin, and WBC were the designated inflammation markers in this study. Recalled weight gain or loss since the age of 20 was obtained from 988 subjects (94%) and classified into the 5 categories: more than half of the participants reported weight gain of 4 kg or more since the age of 20. Table 2 shows the sex-and age-adjusted means and percentages of variables related to body weight or weight change and of the other investigated markers by CRP quartile. Additionally, the partial correlation coefficients were calculated, adjusted for sex and age. The BMI and level of body fat significantly increased with increasing CRP concentration, and their correlation coefficients were relatively high. The percentages of those who reported weight gain since the age of 20 were significantly different between the CRP quartiles, whereas the percentages of those having gained at least 2 kg in the past 6 months were not significantly different. There were significant positive associations of LDL cholesterol, uric acid, serum creatinine, -GTP and a significant negative association of HDL cholesterol with log CRP.
The BMI was not associated with fibrinogen quartile; however, that of body fat was significant (Table 3) . Percentage of weight gain since the age of 20 was significantly different between the fibrinogen quartiles, although the percentage did not clearly increase with higher concentrations of fibrinogen. The associations of fibrinogen with lipids, uric acid, and serum creatinine were similar to those of CRP. Indicators of hepatic function were negatively associated with fibrinogen values. A high percentage of current smokers and a lower percentage of current alcohol drinkers were represented in the higher fibrinogen concentrations.
The highest quartile of serum albumin showed the higher BMI and levels of body fat, and a high percentage of weight gain (Table 4) . With regard to the other variables, positive significant associations with systolic or diastolic blood pressure, total cholesterol, LDL cholesterol, HDL cholesterol, and -GTP were noted.
The associations of the WBC quartile with BMI, body fat, and weight gain were significant and similar to those of CRP ( Table 5 ). The means of total cholesterol, LDL cholesterol, uric acid, serum creatinine, and -GTP significantly increased, and the mean of HDL cholesterol decreased according to WBC. In particular, the percentage of current smokers in the highest quartile of WBC was 42.7% and higher than in other quartiles.
We looked at the association of CRP, fibrinogen, and WBC with the investigated variables, adjusting for smoking status because smoking strongly influences the inflammation markers (data not shown), and significant associations remained after the adjustment.
We calculated the multivariate-adjusted odds ratios of the BMI category (normal: 18.5-24.9; obese: ≥25 kg/m 2 ) or high body fat (≥30% for men and ≥35% for women) for elevated CRP, fibrinogen, WBC, and lowered serum albumin using logistic models (Table 6 ). For elevated CRP, the odds ratios for normal and obese versus lean were 1.54 (95% confidence interval (CI), 0.69-3.42) and 2.50 (95% CI, 1.09-5.75), respectively; odds ratios for other inflammation variables did not significantly increase. For high body fat, fibrinogen also yielded a significant odds ratio of 1.81 (95% CI, 1.02-3.21).
Fig 1 is a box plot of CRP concentration by weight change since the age of 20. Although CRP concentrations were almost equal among people with weight loss or stable weight, those in the group that gained 10 kg or more were significantly high compared with the stable group. Multivariate analysis adjusting for the confounders of sex, age, current obesity, and smoking status was also done (data not shown) and an association of weight change with CRP concentration was independent of current obesity.
Discussion
Population-based cross-sectional studies in the US or European countries have indicated strong associations of inflammation markers with coronary risk factors; [16] [17] [18] ever, Japanese data have not documented this association. Although clear associations of obesity with the CRP value have been reported, [9] [10] [11] [19] [20] [21] there have been few studies comparing the different types of inflammation markers for obesity.
We focused on the association of an increased state of inflammation with obesity and found that each inflammation marker had significant associations with BMI, body fat, or weight gain. In particular, a high concentration of CRP was significantly associated with obesity in the multivariate-adjusted analysis, whereas the association with other markers was attenuated in the multivariate models. In an analysis restricted to subjects aged 40-69 years, body fat level was more strongly associated with CRP and fibrinogen than with BMI. Furthermore, CRP concentration was significantly elevated with weight gain from the age of 20, whereas other inflammatory factors were not.
The recalled weight change was assessed by the Japanese Health Practice Index (JHPI) questionnaire, 22 which assesses the amount of weight gained or lost since the age of 20. We did not validate the assessment; however, previous studies have validated the use of recalled weight for epidemiological studies, 23, 24 and in fact, a strong association of recalled weight change from age 20 with CRP concentration has been noted using data from US populations. 9 There are potential direct mechanisms that may explain our finding that CRP was more closely related to BMI, body fat, and weight gain than other inflammation markers, and that body fat levels were a more important factor for the elevation of CRP concentration. 25, 26 The synthesis of CRP is regulated by the proinflammatory cytokine IL-6 in the liver and IL-6 is released by the adipose tissue, which is associated with BMI, waist-to-hip ratio, and the subscapular-to-triceps ratio. 19 Moreover, an interventional study confirmed that reducing body weight linearly decreased CRP concentration in obese women. 19, 27 Significant associations of fibrinogen with BMI have not been found in other epidemiological studies, 28, 29 which may be explained by negative associations with AST, ALT, and -GTP (r=-0.07 to -0.13). Indeed, obese persons had worse hepatic function, because of a fatty liver, which suggests that synthesis of fibrinogen in the liver might be less. Our data indicate that body fat was significantly associated with higher concentrations of fibrinogen after the adjustment of multivariate confounders including log ALT. Positive associations of serum albumin with BMI, blood pressure, and lipid profiles were recognized in the present study, although a lowered serum albumin concentration is a strong risk factor for cardiovascular events. 30 Some potential mechanisms have been suggested to explain this contradictory issue, 16 but there is no direct evidence so far. The lack of association between WBC and obesity in the present study did not correspond to previous findings among Japanese office workers, 31 possibly because the older population in the present study had a diminished association as WBC counts are generally lowered with aging.
Despite the lack of standardized CRP measurements, CRP concentration are seemingly very low in Japanese populations compared with European or US populations. 13 Given the close relationship of CRP with obesity, a low level of obesity among Japanese may be the reason. Moreover, we believe that given the 4-fold difference in the CHD mortality rates between the USA and Japan, regardless of cholesterol concentration, 32 the low concentration of CRP in Japanese may contribute in part to the low occurrence of CHD events, because of the low prevalence of obesity.
Study Limitations
First, we combined data from males and females rather than using sex-specific data because the statistical power would be low in the stratified analysis, although sex differences of the CRP concentration for BMI or body fat have been indicated. 17 Secondly, our CRP measurement was not a highly sensitive assay and we could not detect a very low concentration of CRP (<0.01 mg/dl), which may underestimate the relationship between CRP and obesity because 2.3% of the present subjects had undetectable CRP concentrations. Third, the variability of the inflammation markers should be considered. The variability of log CRP between individuals was moderate when measured 1 year apart by the same method after excluding persons having a cold (r=0.38), whereas the variability of fibrinogen, serum albumin, and WBC was high (r=0.62 to 0.73). Similar intraindividual variability of CRP values has been reported among Japanese. 33, 34 Finally, we excluded cases having a cold because their CRP and fibrinogen values were significantly high. We also assessed the subject's history of cancer or an allergic disease, which are conditions that might be expected to increase inflammatory levels, but other inflammatory diseases, such as rheumatoid arthritis, were not assessed because such diseases were considered to be rare among participants of compulsory health check-ups. There were no associations between the investigated histories and inflammatory markers except for having a cold.
Conclusions
We examined the associations of 4 inflammation markers with BMI, body fat, and weight gain and found close relationships of CRP with the obesity indicators in a general Japanese population. Our findings imply that weight loss may have a potential effect on reducing the CRP concentration among Japanese similar to that shown in Canadian women. 27 The PRINCE (The Pravastatin Inflammation/CRP Evaluation) study demonstrated that pravastatin reduced CRP concentrations through the anti-inflammatory effects of the statin, 35 and in the near future, a new medical approach targeting high CRP concentration may be the primary prevention strategy for cardiovascular disease. Nonetheless, we should remember that no prospective data yet indicate associations between cardiovascular disease and elevated CRP in Japan and in order to confirm whether or not CRP measurements are beneficial for cardiovascular prevention, epidemiological evidence is urgently needed.
